Carvedilol 25mg tablets

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: MHRA (Medicines & Healthcare Products Regulatory Agency)

Գնել հիմա

Ակտիվ բաղադրիչ:

Carvedilol

Հասանելի է:

DE Pharmaceuticals

ATC կոդը:

C07AG02

INN (Միջազգային անվանումը):

Carvedilol

Դոզան:

25mg

Դեղագործական ձեւ:

Oral tablet

Կառավարման երթուղին:

Oral

Դաս:

No Controlled Drug Status

Ռեկվիզորի տեսակը:

Valid as a prescribable product

Ապրանքի ամփոփագիր:

BNF: 02040000

Տեղեկատվական թերթիկ

                                A
NN
EXU
RE-
1
(Ref.
SOP.
No.:
DFD080)
ART
WORK
APPR
OVAL
FORM
_R_
_elon_
_@hem _
PATIENT
INFORMATION
LEAFLET:
lnfonnatfon
for
the
user
CARVEDI
LOL
3.125
mg,
6.25
mg,
12.5
mg
&
25
mg
TABL
ETS
Read
111
of
this feaRet carefully before you atart taking this medicine
btcause
h
contains
Important I
nformation
f
or
yo
u.
Keep
thi
s
leal1el.
You
may need to
read
It
again.
If
you
have further questions. please ask
)'OUr
dod.ororyour
pharmaci
st
This medicine
has
been presttibed for
you
only.
Do
nol
pas.sit
on to
olhers;
it
may
harm
them,
eve
n
if
their symptoms are the same
as
you
which
Is
being
tr
ei
Hed
by
medicines glven
In
to
your
11
etns (lntrav
                                
                                Կարդացեք ամբողջական փաստաթուղթը
                                
                            

Ապրանքի հատկությունները

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Teva Carvedilol 25 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet contains 25 mg of carvedilol.
Excipient(s) with known effect:
Each tablet also contains 86.25mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
White to off-white, round flat tablet. Scored on one side, debossed on
the other side
with “CVL” on top and “T4” on bottom. The tablet can be
divided into equal halves.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Essential hypertension_ _
Chronic stable angina pectoris
Adjunctive treatment of moderate to severe stable chronic heart
failure_ _
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
_ESSENTIAL HYPERTENSION: _
Carvedilol may be used for the treatment of hypertension alone or in
combination with other
antihypertensives, especially thiazide diuretics. Once daily dosing is
recommended, however
the recommended maximum single dose is 25 mg and the recommended
maximum daily dose is
50 mg.
_Adults _
The recommended initial dose is 12.5 mg once a day for the first two
days.
Thereafter, the treatment is continued at the dose 25 mg/day. If
necessary, the dose may be
further increased gradually at intervals of two weeks or more rarely.
_Older people _
The recommended initial dose in hypertension is 12.5 mg once a day
which may also be
sufficient for continued treatment.
However, if the therapeutic response is inadequate at this dose, the
dose may be further
increased gradually at intervals of two weeks or more rarely.
_CHRONIC STABLE ANGINA PECTORIS: _
A twice-daily regimen is recommended.
_Adults _
The initial dosage is 12.5 mg twice a day for the first two days.
Thereafter, the treatment is
continued at the dose 25 mg twice a day. If necessary, the dose may be
further increased
gradually at intervals of two weeks or more rarely to the recommended
maximum dose of 100
mg a day divided into two doses (twice daily).
_Older people _
The recommended initial d
                                
                                Կարդացեք ամբողջական փաստաթուղթը
                                
                            

Փնտրեք այս ապրանքի հետ կապված ահազանգերը

Դիտել փաստաթղթերի պատմությունը